CIENCIASMEDICASNEWS: SARS-CoV-2 Serological Assay

martes, 7 de abril de 2020

SARS-CoV-2 Serological Assay

	Infectious Diseases
	The latest infectious diseases news from News Medical

Johns Hopkins researchers warn of new infectious diseases and death due to global warming

SARS-CoV-2 Serological Assay

There is an urgent need to increase the current diagnostic capacity for COVID-19. To support the development of immunodiagnostic assay, Sino Biological has developed a comprehensive collection of antigens and antibodies for SARS-CoV-2. These reagents have been used to manufacture NMPA-approved diagnostic kits in China.

Find Out More

			Elsevier’s analysis on global research trends in infectious diseases Over the past two decades, the world has faced several infectious disease outbreaks. Ebola, Influenza A (H1N1), SARS, MERS, Zika virus and currently COVID-19 have had a massive global impact in terms of economic disruption, strain on local and global public health resources and, above all, human health.

			COVID-19 and its effects on the cardiovascular system Researcher have reviewed the evidence showing the effects of the SARS-CoV-2 or novel coronavirus infection (COVID-19) on the cardiovascular system. Their study titled, “Potential Effects of Coronaviruses on the Cardiovascular System: A Review,” was published in the latest issue of JAMA Cardiology.

	Will 'old faithful' tuberculosis BCG vaccine work against COVID? All over the world, except in China, the place where it all began, the COVID-19 pandemic is making its relentless way through the population.

	Guidelines and best practices to provide care for seniors during COVID-19 pandemic Older adults are at elevated risk for complications from COVID-19 and are dying at a higher rate than younger patients.

	New research initiative to investigate multi-species response to novel coronavirus Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).